- Independent hospital
Hull NHS Dialysis Unit
Assessment report published 21 July 2026
Contents
Ratings
Our view of the service
Hull NHS Dialysis Unit is run by Fresenius Medical Care Renal Services Limited, an independent healthcare provider. It is a private dialysis unit located in the grounds of Hull Royal Infirmary in the East Riding of Yorkshire. The unit mainly serves people from Hull and East Yorkshire but also accepts referrals from outside the area.
NHS England commissions the service to provide renal dialysis for NHS patients. Patients are referred by NHS trusts, mainly from a local renal unit.
The unit has 40 dialysis stations and was treating 189 patients at the time of our assessment. It uses advanced Fresenius dialysis machines to treat people with kidney failure.
The service provides haemodialysis for stable patients with end-stage renal disease. Haemodialysis removes waste and excess fluid from the blood when the kidneys can no longer do this.
The service also provides haemodialysis for acute patients, newly diagnosed or long-term haemodialysis patients who are inpatients. The unit also supports three other satellite units by providing haemodialysis to patients not suitable for treatment in a peripheral satellite unit.
The unit opens 6 days a week, Monday to Saturday, with morning and afternoon sessions. It does not provide overnight care. Staff run 2 to 3 sessions each day, including a twilight session on Monday, Wednesday and Friday. Each session treats up to 36 patients, giving a maximum daily capacity of 108.
The service also provides home haemodialysis. At the time of our assessment, 2 patients were training for this.
We last inspected the service in October 2017. This assessment checked whether the provider had met the requirements of a warning notice issued after our inspection in April 2017.
After that inspection, the provider submitted an action plan to address breaches of Regulation 13 (Safeguarding) and Regulation 20 (Duty of Candour).
During this assessment, we found ongoing concerns about safeguarding and duty of candour. Staff did not have the skills or knowledge to recognise and report safeguarding concerns. Only 10% of staff had completed duty of candour training.
We also found breaches of regulation relating to medicines management and governance.